Year in Review: Type 2 Diabetes New approvals, guidance on GLP-1s before surgery, and access issues led the news in 2023 Nov 01, 2023
Wegovy and Thyroid Cancer; Maine Shooter's Mental Health; 469 Heat Deaths Health news and commentary from around the Web gathered by ľֱ staff Oct 30, 2023
Another Study Highlights Metformin's Dementia Protection Properties Association appeared irrespective of HbA1c level Oct 25, 2023
CVS Pulls Phenylephrine Cold Meds; Doc's Murder/Suicide; Red Meat and Diabetes Health news and commentary from around the Web gathered by ľֱ staff Oct 20, 2023
Highly Potent Statin Stands Out for Diabetes, Cataract Risks Head-to-head comparison of rosuvastatin vs atorvastatin in LODESTAR trial Oct 19, 2023
Time to Recognize Cardiovascular-Kidney-Metabolic Syndrome, AHA Says Pooled cohort equations will make way for new CKM risk calculator Oct 09, 2023
Inflammation of the Aorta; Afib in the Hospital Also in TTHealthWatch: standards for osteoporosis screening and HbA1c in premenopausal women Oct 07, 2023 podcast
CPAP Turns in Mixed Results for Patients With Diabetic Eye Disease Slower progression of retinal disease, but an increase in microhemorrhages Oct 06, 2023
Smoking-Related Metabolic Changes Partly Drive Type 2 Diabetes Risk Those with the most metabolic changes, genetic risk had a threefold higher diabetes risk Oct 06, 2023
Faster-Acting Insulin Aspart Safe for Pregnant Women With Diabetes The faster formulation led to fewer hypoglycemia events versus conventional insulin aspart Oct 06, 2023
Hybrid Closed-Loop Insulin System for T1D Safe, Effective During Pregnancy However, no FDA-approved systems have a pregnancy indication yet Oct 05, 2023
Mixed Bag for Early Metformin in Gestational Diabetes EMERGE trial misses on primary endpoint, but secondary outcomes suggest potential benefit Oct 03, 2023
Adding Tirzepatide to Basal Insulin Cuts HbA1c in Poorly Controlled T2D Results with the GIP/GLP-1 receptor agonist were statistically superior to added insulin lispro Oct 03, 2023
FDA Adds Intestinal Blockage Reports to Ozempic Labeling Joins other approved GLP-1 receptor agonists in noting the potential adverse reaction Sep 28, 2023
Postmenopausal Fracture Risk for SGLT2 Inhibitors Similar to Other Diabetes Drugs Lower risk compared with DPP-4 inhibitors, and similar risk versus GLP-1 receptor agonists Sep 26, 2023
FDA Approves Another SGLT2 Inhibitor for Treating CKD Empagliflozin adds indication in adults, regardless of diabetes status Sep 22, 2023
FDA Panel: All Thumbs Down for GLP-1 Agonist Implant for Diabetes We haven't seen "the best version of this device," said panel member Sep 22, 2023
Third Time's a Charm for GLP-1 Diabetes Device? FDA Staff Suggest Otherwise. Advisory committee to weigh in on safety concerns with GLP-1 receptor agonist implant Sep 20, 2023
Direct-to-Consumer Lab Tests Raise Ethical Questions, Researchers Say Privacy policies, terms of sale often are unclear Sep 18, 2023
Is Being a Night Owl Unhealthy? CRC Screening Not Recommended Enough Also in TTHealthWatch: CVD death and obesity Sep 16, 2023 podcast
Mask Attack Leaves Actor Blind; Diabetes Risk in Night Owls; U.S. Blood Shortage Health news and commentary from around the Web gathered by ľֱ staff Sep 12, 2023
When Temps Rise, So Do Medical Risks. Should Docs and Nurses Talk More About Heat? "This is not your grandmother's heat," says policy expert Sep 10, 2023
New Weight-Loss Drugs Spark Debate About Safety During Surgery Some anesthesiologists think current guidelines don't go far enough Sep 08, 2023
Low-Dose Semaglutide Can Ease Insulin Need in Early T1D, Small Series Shows All 10 patients were able to eliminate prandial insulin use within 3 months Sep 06, 2023
Case Grows for SGLT2 Inhibitors as Gout Treatment Large cohort study shows expansive benefits Aug 28, 2023
SGLT2 Inhibitors, Rapid Titration, IV Iron Get a Boost in New European HF Guideline Other recommendations also released for endocarditis, cardiomyopathies, ACS, and more Aug 25, 2023
Should People Without Diabetes Use Glucose Monitors? Trend boosted by health buffs on social media, but benefit for healthy adults is unclear Aug 01, 2023
Kombucha Shows Potential Diabetes Benefit in Small Trial Diabetes patients saw glucose levels drop after drinking fermented tea Aug 01, 2023
Albuminuria Testing Falling Short in Patients at Risk for CKD If testing rates followed recommendations, some could start necessary meds sooner Jul 27, 2023
Aspartame Is a 'Possible' Carcinogen, WHO Declares But the organization's recommended limits on aspartame consumption remain unchanged Jul 13, 2023
Diabetes Projected to Affect 1.3 Billion People by 2050 Advance of disease driven by high BMI, with social determinants of health playing a role Jun 28, 2023
Protocol Optimizing Meds for T2D and CVD Pushed Beyond Cardiology Alone Endocrinologists urged to pay attention to COORDINATE trial Jun 27, 2023
Semaglutide Plus Cagrilintide Reduced Blood Sugar, Weight in T2D Once-weekly CagriSema reduced body weight more than either agent alone Jun 27, 2023
High-Dose Semaglutide Pill Just as Effective as Wegovy for Weight Loss Another study showed two high doses were better at reducing HbA1c vs a 14-mg dose Jun 27, 2023
Novel Triple Agonist Nabs Biggest Weight Loss Yet in Obesity Trial Plus, two other studies on retatrutide show benefit in type 2 diabetes, fatty liver disease Jun 26, 2023
Bempedoic Acid Gets 'Huge' Win for Primary Prevention in the Statin-Intolerant More positive results in CLEAR Outcomes sub-analysis Jun 26, 2023
Once-Weekly Insulin Icodec Bests Daily Insulin Options for Type 2 Diabetes Superior to once-a-day insulin glargine U100 and degludec Jun 25, 2023
Near 15% Weight Loss With Novel Oral GLP-1 RA in Phase II Obesity Trial Daily orforglipron also lowered HbA1c in type 2 diabetes Jun 24, 2023
Novel Agent Leads to Fibrosis Improvement in NASH Phase IIb ENLIVEN trial saw success with various doses of pegozafermin Jun 24, 2023
Expunge Nazi-Era Medical Terms? Off-Brand Wegovy Clinics Sued; Copy and Paste Bloat Health news and commentary from around the Web gathered by ľֱ staff Jun 21, 2023
